FindTrial
Sign In

The application of ultrasound sclerotherapy in patient with hydrosalpinx undergoing IVF-ET treatment

An assessor-blind, open-label, Randomized, Parallel-group, Non-inferiority Study to compare the clinical pregnancy rate of interventional ultrasound sclerotherapy to surgical intervention on women with hydrosalpinx before in vitro fertilization and embryo transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008961
Enrollment
Unknown
Registered
2016-08-02
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hydrosalpinx

Interventions

Surgery group:Surgery
Experimental group:ultrasound sclerotherapy

Sponsors

The 105th Hospital of People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral or bilateral hydrosalpinges visible by ultrasound; 2. Aged between 20 - 37 years; 3. Period of infertility > 1 year; 4. Body mass index between 19-29; 5. Normal basal luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin concentrations; 6. AFC=7; 7. AMH level 0.24-11.78ng/ml; 8. midluteal phase gonadotropin-releasing hormone agonist (GnRH-a) long down-regulation protocol; 9. Normal recent semen analysis (according to World Health Organization criteria).

Exclusion criteria

Exclusion criteria: 1. Uterine fibroid requiring surgical removal; 2. Endometriosis or adenomyosis; 3. Male factor of infertility requiring ICSI; 4. Previous IVF cycles; 5. History of recurrent miscarriage; 6. Endocrinologic disorders; 7. Presence of systemic disease contraindicating pregnancy.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;live birth rate;—

Secondary

MeasureTime frame
Pregnancy Loss rate;ectopic pregnancy rate;Ongoing pregnancy in a transfer cycle;—

Contacts

Public ContactHong Jiang

Reproductive Medicine Center, The 105th Hospital of PLA

jiangh105@sina.com+86 0551-65966361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026